Last10K.com

Alere Inc. (ALR) SEC Filing 8-K Material Event for the period ending Saturday, July 15, 2017

Alere Inc.

CIK: 1145460

View differences made from one to another to evaluate Alere Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Alere Inc..

Continue

Assess how Alere Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Alere Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2017 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Alere Inc. provided additional information to their SEC Filing as exhibits

CIK: 1145460
Form Type: 8-K Corporate News
Accession Number: 0000950142-17-001346
Submitted to the SEC: Mon Jul 17 2017 5:12:07 PM EST
Accepted by the SEC: Mon Jul 17 2017
Period: Saturday, July 15, 2017
Industry: In Vitro And In Vivo Diagnostic Substances
Events:
  1. Financial Exhibit
  2. New Agreement

External Resources:
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/1145460/0000950142-17-001346.htm